19 hours ago . Below is a look at some of the headlines for companies that made news in the

Feb 29, 2012 . Royalty Pharma will now get payments on sales of Cimzia, a drug that is sold by

Aug 13, 2010 . Following a transfer of royalty interests to Royalty Pharma, . because you

Company profile for Royalty Pharma in New York,NY. Get accurate business

royaltypharma.com reviewed ligand.com, emoryhealthcare.org.

Royalty Pharma is an $8B private equity firm based in New York that invests in

Royalty Pharma. Acquisition of royalty interests in marketed and late stage

Jan 5, 2012 . A new way for cash-starved biotechs to raise money. Cowen Healthcare Royalty

Welcome to the company profile of Royalty Pharma on LinkedIn. Royalty Pharma

21 hours ago . Sunesis Contacts: David Pitts. Argot Partners. 212-600-1902. Eric Bjerkholt.

23 hours ago . Sunesis Pharmaceuticals (Nasdaq: SNSS) and Royalty Pharma announced that

Royalty Pharma Management LLC company profile in New York, NY. Our free

Royalty Pharma has created a rapidly growing company within the

Feb 12, 2009 . This week's IP Market Player is Royalty Pharma. The name has begun to pop up

Feb 29, 2012 . Nektar Therapeutics (NASDAQ:NKTR): Nektar Therapeutics announced that it

Royalty Pharma acquires royalty interests in marketed and late stage

20 hours ago . Sunesis Pharmaceuticals (SNSS) and Royalty Pharma announced that Royalty

19 hours ago . Sunesis and Royalty Pharma Announce $25 Million Vosaroxin Royalty A.. .

Aug 11, 2011 . Arisaph Pharmaceuticals, Inc. (“Arisaph”) and Royalty Pharma . Under the terms

Jun 30, 2011 . Under the terms of the sale agreement, Royalty Pharma will be entitled to receive

Jul 13, 2011 . Royalty Pharma Finance Trust, a company that acquires revenue-producing

Apr 5, 2011 . Royalty Pharma has acquired the rights to certain royalties payable on sales of

Jan 24, 2011 . BioLineRx (TASE:BLRX) today announced that it has been advised by Royalty

Royalty Pharma's detailed financings; Comprehensive pipeline breakdown,

Sep 30, 2009 . Selling royalty interests in health care products was once a vehicle mainly for

GILEAD SCIENCES AND ROYALTY PHARMA ANNOUNCE $525 MILLION

2 hours ago . SOUTH SAN FRANCISCO, Calif., March 29, 2012 -- Sunesis Pharmaceuticals

23 hours ago . NASDAQ News: Sunesis and Royalty Pharma Announce $25 Million Vosaroxin

NEW YORK, April 24 /PRNewswire/ -- The Children's Hospital Foundation, the

Royalty Pharma Raises $3.6 Billion to Refinance $2.75 Billion of Outstanding

Jul 18, 2005 . Gilead and Royalty Pharma made a one-time cash payment of $525.0 million to

Mr. Legorreta founded Royalty Pharma in 1996, after creating and managing two

Pharmaceutical Royalties in Licensing Deals: No Place for the 25% Rule of

23 hours ago . SOUTH SAN FRANCISCO, Calif., March 29, 2012 (GLOBE NEWSWIRE) --

Royalty Pharma is a rapidly growing company that owns and acquires revenue-

Royalty Pharma. See all tags ». December 29, 2011, 12:11 pm. Deal Professor.

23 hours ago . Sunesis Pharmaceuticals (Nasdaq: SNSS) and Royalty Pharma today

85 Check-ins at Royalty Pharma "33rd Floor." . Royalty Pharma. 110 E 59th St. (

23 hours ago . SOUTH SAN FRANCISCO, Calif., March 29, 2012 (GLOBE NEWSWIRE) --

Royalty Pharma AG Announces that James Reddoch, Ph.D., Joins Management

Sep 7, 2011 . Royalty Pharma refinanced $2.75 billion of outstanding debt and funded a one-

9 hours ago . menafn: Sunesis Pharmaceuticals signs royalty agreement with Royalty Pharma

Royalty Pharma Acquires Cypress . In 2011, Royalty Pharma, the industry

Royalty Pharma Management Inc New York reviews by real people. Yelp is a fun

Apr 4, 2011 . NEW YORK, NY--(Marketwire - April 4, 2011) - Royalty Pharma announced today

Feb 29, 2012 . Nektar sold the potential royalty revenue from those two products to a unit of

23 hours ago . From Yahoo! Finance: SOUTH SAN FRANCISCO, Calif. -- Sunesis

Royalty Pharma company research & investing information. Find executives and

Sep 7, 2011 . NEW YORK, NY--(Marketwire - Sep 7, 2011) - Royalty Pharma, the industry

Jan 6, 2011 . SAN DIEGO and NEW YORK, Jan. 6, 2011 /PRNewswire/ -- Ramius V&O

Sitemap